Evidence map›Paper›PMID 32636988›Full record

ArticleThe Pan African medical journal2020

Cancer ecosystem assessment in West Africa: health systems gaps to prevent and control cancers in three countries: Ghana, Nigeria and Senegal.

Omobolaji Ayandipo, Issa Wone, Ernest Kenu, Luther-King Fasehun, Oluwayemisi Ayandipo, Fatou Gaye, Adedoyin Ojo, Yewande Ayoola, Jarim Omogi, Desta Lakew and 1 more

Abstract read
In one paragraph

Article in The Pan African medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Diagnosis, care pathways, and Complementary and Alternative Medicine (CAM) use among digestive cancer patients in Benin: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Role of Nanoformulations in the Treatment of Lung Cancer.Recent patents on nanotechnology · 2025
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Medical pluralism, healthcare utilization and patient wellbeing: The case of Akan cancer patients in Ghana.International journal of qualitative studies on health and well-being · 2023
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Omobolaji AyandipoDepartment of Surgery, College of Medicine University of Ibadan and University College Hospital, Ibadan, Nigeria.
Issa WoneHealth Sciences Department, University Assane Seck of Ziguinchor, Ziguinchor, Senegal.
Ernest KenuUniversity of Ghana, School of Public Health, Department of Epidemiology and Disease Control, Accra, Ghana.
Luther-King FasehunThe Wellbeing Foundation Africa, Abuja, Nigeria.
Oluwayemisi AyandipoAfrican Field Epidemiology Network, Abuja, Nigeria.
Fatou GayeAmref Health Africa, West Africa hub, 105 Sacre Coeur 3 Dakar, Senegal.
Adedoyin OjoDepartment of Surgery, University College Hospital, Ibadan, Nigeria.
Yewande AyoolaThe Wellbeing Foundation Africa, Abuja, Nigeria.
Jarim OmogiAmref International University P.O. Box. 27691- 00506; Nairobi, Kenya.
Desta LakewAmref Health Africa, Headquarters Langata Road PO Box 27691-0506 Nairobi, Kenya.
Sylla ThiamAmref Health Africa, West Africa hub, 105 Sacre Coeur 3 Dakar, Senegal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSub-Saharan Africa is experiencing a rapid epidemiological transition with the increasing incidence of Non-Communicable Diseases (NCD). Among these, cancer is one of the main causes of death in adults. This is a public health problem whose burden is unknown due to lack of statistical data. In addition, the already overburdened health systems are experiencing enormous constraints to address the problem with the double challenge of communicable and NCDs.

methodsThe purpose of this evaluation was to assess the capacity and needs of health systems to prevent and control cancer. A cross-sectional study, using both quantitative and qualitative methods, was conducted between April 2017 and February 2018 in target countries, through in-depth interviews with key actors, direct observations and documents review. The WHO framework for health system strengthening with the 6 pillars was used for the gaps analysis.

resultsLittle priority is given to the fight against cancer because of low political commitment. Programs´ resources are very limited and there is a poor coordination of the actions. Human resources are insufficient, and most of them are concentrated in the capital city. This limits access to care with a late consultation of patients. Diagnosis and treatment services are expensive and generally paid by households. Finally, the unavailability of reliable data at national level hinders the decision-based evidence.

conclusionThere is an urgent need to create strong partnerships at national and regional levels to (i) Advocate for a strong political commitment; (ii) Strengthen the coordination of actions and create more synergy among stakeholders; (iii) Improve the quality and quantity of human resources; (iv) Extend universal health coverage to cancer and improve program funding; and (v) Set up cancer registries at national level.

Indexed as

Public HealthCross-Sectional StudiesDelivery of Health CareEcosystemGhanaHealthcare FinancingHealth Services AccessibilityHumansInterviews as TopicNeeds AssessmentNeoplasmsNigeriaNoncommunicable DiseasesSenegalCancercontrolneeds assessmentprevention

Identifiers

PMID32636988
PMCPMC7320762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.